Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
Recruiting · NCT05067348 · Registry updated 2025-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 2 | 2025-05-01 | NCT05067348 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tang-Du Hospital | 93 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital, Capital Medical University | Beijing | China | 3 |
| Huashan Hospital | Shanghai | China | 15 |
| Tangdu Hospital, The Fourth Military Medical University | Xi'an | China | 2 |
| Tianjin Medical University General Hospital | Tianjin | China | 61 |
| West China Hospital of Sichuan University | Chengdu | China | 117 |
| Xiangya Hospital Central South University | Changsha | China | 35 |